Company Filing History:
1 out of 67 
1 out of 23 Years Active: 2022
Title: Jorge Moreno Herrero: Pioneering Innovator in RNA Formulations
Introduction:
Jorge Moreno Herrero, a dedicated inventor based in Mainz, DE, is a true pioneer in the world of technology. With a fervent passion for innovation, Jorge has dedicated his career to creating inventions that have a positive impact on society.
Latest Patents:
Jorge Moreno Herrero holds 1 patent for his groundbreaking invention titled "Formulation for administration of RNA." This patent encompasses compositions comprising polyplex formulations for the delivery of RNA to a target organ or cell, especially through intramuscular administration. These formulations consist of polyplex particles from single-stranded RNA and a polyalkyleneimine, encoding proteins of interest for pharmaceutical applications in humans and animals.
Career Highlights:
Jorge Moreno Herrero has made significant contributions to the field of biotechnology through his work with renowned companies such as BioNTech SE and TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH. His expertise in RNA formulations has led to the development of innovative pharmaceutical products for effective parenteral application.
Collaborations:
Throughout his career, Jorge has collaborated closely with esteemed professionals in the industry, including Ugur Sahin and Heinrich Haas. These collaborations have fostered a culture of innovation, leading to the advancement of cutting-edge technologies in the field of biomedicine.
Conclusion:
In conclusion, Jorge Moreno Herrero's unwavering commitment to innovation and his relentless pursuit of creating impactful inventions highlight him as a true trailblazer in the realm of technology. His contributions to RNA formulations have the potential to revolutionize the pharmaceutical industry, thereby benefiting both human and animal health.